Literature DB >> 18761969

European monitoring of notifications of hepatitis C virus infection in the general population and among injecting drug users (IDUs) - the need to improve quality and comparability.

L Wiessing1, Bruno Guarita, Isabelle Giraudon, Henrikki Brummer-Korvenkontio, Mika Salminen, S A Cowan.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18761969     DOI： 10.2807/ese.13.21.18884-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


× No keyword cloud information.
  8 in total

Review 1.  Hepatitis C virus genotype 6: virology, epidemiology, genetic variation and clinical implication.

Authors:  Vo Duy Thong; Srunthron Akkarathamrongsin; Kittiyod Poovorawan; Pisit Tangkijvanich; Yong Poovorawan
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

2.  Epidemiological Data - an Important Part of the Hemovigilance System.

Authors:  Ruth Offergeld; Osamah Hamouda; Reinhard Burger
Journal:  Transfus Med Hemother       Date:  2010-05-20       Impact factor: 3.747

3.  A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations.

Authors:  Nathalie Removille; Alain Origer; Sophie Couffignal; Michel Vaillant; Jean-Claude Schmit; Marie-Lise Lair
Journal:  BMC Public Health       Date:  2011-05-19       Impact factor: 3.295

4.  Are there national strategies, plans and guidelines for the treatment of hepatitis C in people who inject drugs? A survey of 33 European countries.

Authors:  Mojca Maticic; Jerneja Videcnik Zorman; Sergeja Gregorcic; Eberhard Schatz; Jeffrey V Lazarus
Journal:  BMC Infect Dis       Date:  2014-09-19       Impact factor: 3.090

Review 5.  Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention.

Authors:  Lucas Wiessing; Marica Ferri; Bart Grady; Maria Kantzanou; Ida Sperle; Katelyn J Cullen; Angelos Hatzakis; Maria Prins; Peter Vickerman; Jeffrey V Lazarus; Vivian D Hope; Catharina Matheï
Journal:  PLoS One       Date:  2014-07-28       Impact factor: 3.240

6.  Roundtable discussion: how lessons learned from HIV can inform the global response to viral hepatitis.

Authors:  Jeffrey V Lazarus; Jens Lundgren; Jordi Casabona; Lucas Wiessing; Catharina Matheï; Peter Vickerman; Maria Prins; Mirjam Kretzschmar; Maria Kantzanou; Isabelle Giraudon; Marica Ferri; Paul Griffiths; Magdalena Harris; Margaret Walker; Lilyana Chavdarova; Eberhard Schatz; Katrin Schiffer; John Kools; Jason Farell; Luís Mendão
Journal:  BMC Infect Dis       Date:  2014-09-19       Impact factor: 3.090

7.  High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).

Authors:  Benjamin Wenz; Stine Nielsen; Martyna Gassowski; Claudia Santos-Hövener; Wei Cai; R Stefan Ross; Claus-Thomas Bock; Boris-Alexander Ratsch; Claudia Kücherer; Norbert Bannert; Viviane Bremer; Osamah Hamouda; Ulrich Marcus; Ruth Zimmermann
Journal:  BMC Public Health       Date:  2016-09-05       Impact factor: 3.295

8.  Identification of hepatitis C virus in the common bed bug - a potential, but uncommon route for HCV infection?

Authors:  Jiaxin Ling; Thomas Persson Vinnersten; Jenny C Hesson; Jon Bohlin; Espen Roligheten; Edward C Holmes; John H-O Pettersson
Journal:  Emerg Microbes Infect       Date:  2020-12       Impact factor: 7.163
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.